Jaguar Health's stock dropped 59% likely due to profit-taking after a recent sharp rise, despite no new company disclosures. Viking Therapeutics fell 4% following a pullback after positive obesity drug trial data and a special investor call announcement. The broader biotech sector remained stable, indicating these moves are company-specific rather than sector-driven. Investors should watch Viking's upcoming call for more details and monitor if Jaguar Health stabilizes or continues to decline amid its volatile trading.
Jaguar Health and Viking Therapeutics are the story's subjects, with Pluang market data providing context. Of 100 Health-sector US stocks on Pluang, 35 rose and 64 fell as of Sep 23, 2026 20:52 WIB. Notable movers include TLRY at USD 4.14 with a -2.01% change and 100% buy orders, ACAD at USD 25.89 down 1.95%, and SNY at USD 41.72 down 1.86% with 100% buy orders.
Jefferies analysts set a new price target of $435 for General Electric Aerospace, implying a 35% upside from its current price of around $321. GE Aerospace's strong position is supported by a $170 billion commercial services backlog and 80,000 aircra...
BNP Paribas lowered its price target for PepsiCo from $183 to $161 on September 23, 2026, due to ongoing demand challenges in North America. Despite the cut, the firm maintained an Outperform rating, indicating confidence in the stock's potential. Th...
Celldex Therapeutics saw its price target raised from $70 to $88 by Leerink Partners following successful Phase III trial results for its drug barzolvolimab treating chronic spontaneous urticaria (CSU). The trials met all primary endpoints, showing l...
Ero Copper, a major copper producer, shows stock volatility between $16.88 and $40.83 over the past year. Analyst firm CIBC maintained a "Neutral" rating but increased the price target to C$56.00, reflecting optimism about the company's long-term gro...
Cintas Corporation posted robust first-quarter results, surpassing analyst expectations with earnings per share of $1.39 and revenue of $3.01 billion, a 10.9% increase year-over-year. The company's organic revenue growth was 8.9%, reflecting solid bu...
